摘要
前列腺癌是最难治疗的癌症之一,特别是当它变成激素抵抗时,例如去势抵抗性前列腺癌(CRPC)和随后的转移性CRPC。除了前列腺癌的遗传改变之外,表观遗传修饰也在该疾病的发展和肿瘤进展中发挥重要作用。这些包括DNA甲基化,组蛋白修饰和非编码微RNA。 miRNA是一类长度为19-25个核苷酸的小内源性单链非编码RNA,其通常沉默基因表达。考虑到早期癌变过程中表观遗传改变的可逆性,绿茶儿茶素对这些修饰的逆转(校正)可能是癌症化学预防和治疗的有前途的策略。最近的证据表明绿茶儿茶素如表没食子儿茶素没食子酸酯(EGCG)不仅作为表观遗传调节剂,而且还可以修饰miRNA表达及其靶mRNA,一直有助于抑制前列腺癌发生。各种研究还表明,几种绿茶多酚(GTPs)与其他癌症化疗剂发挥协同作用。因此,使用绿茶儿茶素与现有化学治疗剂的适当组合将导致副作用减少而不降低化疗效果。这篇综述将总结最近研究的关键结果,详细描述绿茶儿茶素如EGCG对前列腺癌中表观遗传学改变和miRNA表达的影响。
关键词: 前列腺癌,miRNAs,儿茶素,多酚,表观遗传学改变。
Current Molecular Medicine
Title:Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer
Volume: 17 Issue: 6
关键词: 前列腺癌,miRNAs,儿茶素,多酚,表观遗传学改变。
摘要: Prostate cancer is one of the most difficult cancers to treat especially when it becomes hormone resistant such as castrate resistant prostate cancer (CRPC) and subsequent metastatic CRPC. Apart from the genetic alterations in prostate cancer, epigenetic modifications also play an important role in the development and neoplastic progression of this disease. These include DNA methylation, histone modifications, and non-coding microRNAs. miRNAs are a novel class of small endogenous single-stranded non-coding RNAs of 19-25 nucleotides in length that typically silence gene expression. Considering the reversibility of epigenetic alterations in early carcinogenesis process, reversion (correction) of these modifications by green tea catechins could be a promising strategy for cancer chemoprevention and therapy. Recent evidence suggests that green tea catechins such as epigallocatechin gallate (EGCG) not only act as epigenetic modulators but can also modify miRNA expression and their target mRNAs, consistently contributing to the inhibition of prostate carcinogenesis. Various studies also indicate that several green tea polyphenols (GTPs) exert synergistic effects with other cancer chemotherapeutic agents. Therefore, the use of appropriate combinations of green tea catechins with the existing chemotherapeutics will lead to a reduction in side effects without decreasing the chemotherapeutic effects. This review will summarize the key results from recent studies detailing the effects of green tea catechins such as EGCG on epigenetic alterations and miRNA expression in prostate cancer.
Export Options
About this article
Cite this article as:
Epigenetic Changes Induced by Green Tea Catechins a re Associated with Prostate Cancer, Current Molecular Medicine 2017; 17 (6) . https://dx.doi.org/10.2174/1566524018666171219101937
DOI https://dx.doi.org/10.2174/1566524018666171219101937 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alkaloid-Metal Based Anticancer Agents
Current Topics in Medicinal Chemistry The Possibility of Preventive and Therapeutic Use of Green Tea Catechins in Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
Anti-Cancer Agents in Medicinal Chemistry STAT3: A Molecular Target for Cancer Whose Time Has Come
Current Signal Transduction Therapy Chemical Diversity of Grape Products, a Complex Blend of Bioactive Secondary Metabolites
The Natural Products Journal The Potential use of Dendritic Cell-based Immunotherapy for Treatment of Pancreatic Cancer
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Biomedical Applications of Carbon Nanotubes: A Critical Review
Current Drug Delivery Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick
Mini-Reviews in Medicinal Chemistry ES-MDA: Enhanced Similarity-based MiRNA-Disease Association
Current Protein & Peptide Science Recent Patents Relating to Tumor Suppressor Genes
Recent Patents on DNA & Gene Sequences The Dynamics of the Hypothalamic-Pituitary-Ovarian Axis, ReproductivePerformance and Sexuality Following Bariatric Surgery
Current Women`s Health Reviews “SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain
Current Neurovascular Research Therapeutic Value of an Integrin Antagonist in Prostate Cancer
Current Drug Targets Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise
Current Pharmaceutical Design Quantitative Proteomics Profiling of RKO and HT29 Cell Lines by iTRAQ Coupled LC-MS/MS
Current Proteomics The Control of Cell Cycle in Mouse Primordial Germ Cells: Old and New Players
Current Pharmaceutical Design Human Kallikreins: Common Structural Features, Sequence Analysis and Evolution
Current Genomics Effect of Oral Methadone on ECG Characteristics and Endocrine Hormonal Changes and Their Inter-relationship
Endocrine, Metabolic & Immune Disorders - Drug Targets E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment
Mini-Reviews in Medicinal Chemistry Cellular Senescence-Inducing Small Molecules for Cancer Treatment
Current Cancer Drug Targets